Episode 12
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on April 22, 2024 11:06 ()
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 407524160 series 3562806
In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks, discussing buprenorphine vs methadone treatment for OUD, the link between gabapentinoids and COPD exacerbations, the significant decrease in overdose mortality rates seen in Sweden after rolling out take-home naloxone, and more!
Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study, Published in the Annals of Internal Medicine, January 2024
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies Published in the Lancet Journal of Psychiatry- May 2023
Addressing the Spectrum of Opioid Misuse Prevention, Treatment, and Recovery in Rural Washington State Communities: Provider Identified Barriers and Needs Published in the Community Mental Health Journal, January 2024
Distribution of intranasal naloxone to potential opioid overdose bystanders in Sweden: effects on overdose mortality in a full region-wide study Published in the BMJ Open, January 2024
Association of therapies with reduced pain and improved quality of life in patients with fibromyalgia: a systematic review and meta-analysis Published in JAMA Internal Medicine, January 2021
19 episod